2022至2024年儿童COVID-19住院特征及重症危险因素
结果显示58.9%的住院儿童至少有一种基础疾病,仅3.8%按推荐完成COVID-19疫苗接种;6-23月龄儿童重症与慢性肺病和心血管病相关,2岁及以上儿童重症与慢性肺病、糖尿病和神经系统疾病相关。
要点
- 住院儿童中58.9%至少有一种基础疾病,仅3.8%按推荐完成COVID-19疫苗接种。
- 6-23月龄住院儿童重症与慢性肺病(aRR 1.5)和心血管病(aRR 1.4)相关。
- 2岁及以上住院儿童重症与慢性肺病(aRR 1.9)、糖尿病(aRR 1.5)和神经系统疾病(aRR 1.4)相关。
核心结论
- 大多数6月龄以上COVID-19住院儿童至少有一种基础疾病,且不足5%按推荐完成COVID-19疫苗接种。
- 特定基础疾病与重症风险增加相关,提高COVID-19疫苗接种率(尤其高危儿童)可能减少住院和重症结局。
研究设计与样本
- 采用多变量对数链接Poisson广义估计方程,分别评估6-23月龄和2-17岁儿童重症的危险因素。
主要发现
- 2490例住院儿童中,1114例(44.7%)为6-23月龄,1358例(54.1%)为男性。
- 1464例(58.9%)至少有一种基础疾病:6-23月龄471例(41.8%),2-4岁290例(61.6%),5-11岁383例(79.2%),12-17岁320例(77.0%)。
- 6-23月龄儿童中,重症与慢性肺病(aRR 1.5;95%CI 1.2-1.8)和心血管病(aRR 1.4;95%CI 1.1-1.7)相关。
- 2岁及以上儿童中,重症与慢性肺病(aRR 1.9;95%CI 1.5-2.3)、糖尿病(aRR 1.5;95%CI 1.2-1.8)和神经系统疾病(aRR 1.4;95%CI 1.2-1.6)相关。
关键数值与推荐
- 重症定义为入住重症监护室、机械通气、体外膜肺氧合或院内死亡。
- 6-23月龄:慢性肺病aRR 1.5(95%CI 1.2-1.8),心血管病aRR 1.4(95%CI 1.1-1.7)。
- 2岁及以上:慢性肺病aRR 1.9(95%CI 1.5-2.3),糖尿病aRR 1.5(95%CI 1.2-1.8),神经系统疾病aRR 1.4(95%CI 1.2-1.6)。
临床怎么用
- 对6月龄以上儿童,尤其合并慢性肺病、心血管病、糖尿病或神经系统疾病者,应重视COVID-19疫苗接种以降低住院和重症风险。
- 住院评估时需关注上述基础疾病,识别重症高危患儿。
局限性
- 数据仅来自COVID-NET监测区域,可能影响外推性。
- 疫苗接种状态按推荐完成定义,未进一步分析部分接种或既往感染的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We assessed characteristics associated with pediatric COVID-19 hospitalizations and risk factors for severe disease among hospitalized children aged 6 months and older. METHODS: Using data from COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) during October 1, 2022, to April 30, 2024, we described demographic characteristics, underlying medical conditions, COVID-19 vaccination status, and clinical outcomes, including severe disease (intensive care unit admission, mechanical ventilation, extracorporeal membrane oxygenation, in-hospital death), of hospitalized children aged 6 months to 17 years residing in the COVID-NET catchment area with laboratory-confirmed SARS-CoV-2 infection. Multivariable log-linked Poisson generalized estimating equations were conducted to assess risk factors for severe disease among children aged 6 to 23 months and 2 to 17 years. RESULTS: Of 2490 children hospitalized for COVID-19, 1114 (44.7%) were aged 6 to 23 months; 1358 (54.1%) were male. Overall, 1464 (58.9%) had at least 1 underlying condition: 471 (41.8%) of children aged 6 to 23 months, 290 (61.6%) aged 2 to 4 years, 383 (79.2%) aged 5 to 11 years, and 320 (77.0%) aged 12 to 17 years. One hundred (3.8%) were up to date with recommended COVID-19 vaccination. Among children aged 6 to 23 months, severe disease was associated with underlying chronic lung (adjusted risk ratio [aRR], 1.5; 95% CI, 1.2-1.8) and cardiovascular disease (aRR, 1.4; 95% CI, 1.1-1.7). Among children aged 2 years and older, severity was associated with chronic lung disease (aRR, 1.9; 95% CI, 1.5-2.3), diabetes (aRR, 1.5; 95% CI, 1.2-1.8), and neurologic disorders (aRR, 1.4; 95% CI, 1.2-1.6). CONCLUSION: Most hospitalized children aged 6 months and older had at least 1 underlying condition, and less than 5% were up to date with COVID-19 vaccination. Specific conditions were associated with increased risk of severe illness. Increasing COVID-19 vaccination, particularly among children with high-risk conditions, may reduce pediatric COVID-19 hospitalizations and severe outcomes.
引用
- Free RJ, Patel K, Taylor CA, et al. Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022-2024. Pediatrics. 2025. PMID: 40604359. doi:10.1542/peds.2025-072788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。